Miyawaki-Shimizu Kayo, Predescu Dan, Shimizu Jun, Broman Michael, Predescu Sanda, Malik Asrar B
Dept. of Pharmacology, Univ. of Illinois College of Medicine, 835 So. Wolcott Ave. M/C868 Chicago, IL 60612, USA.
Am J Physiol Lung Cell Mol Physiol. 2006 Feb;290(2):L405-13. doi: 10.1152/ajplung.00292.2005. Epub 2005 Sep 23.
Caveolin-1, the principal integral membrane protein of caveolae, has been implicated in regulating the structural integrity of caveolae, vesicular trafficking, and signal transduction. Although the functions of caveolin-1 are beginning to be explored in caveolin-1-/- mice, these results are confounded by unknown compensatory mechanisms and the development of pulmonary hypertension, cardiomyopathy, and lung fibrosis. To address the role of caveolin-1 in regulating lung vascular permeability, in the present study we used small interfering RNA (siRNA) to knock down caveolin-1 expression in mouse lung endothelia in vivo. Intravenous injection of siRNA against caveolin-1 mRNA incorporated in liposomes selectively reduced the expression of caveolin-1 by approximately 90% within 96 h of injection compared with wild-type mice. We observed the concomitant disappearance of caveolae in lung vessel endothelia and dilated interendothelial junctions (IEJs) as well as increased lung vascular permeability to albumin via IEJs. The reduced caveolin-1 expression also resulted in increased plasma nitric oxide concentration. The nitric oxide synthase inhibitor L-NAME, in part, blocked the increased vascular albumin permeability. These morphological and functional effects of caveolin-1 knockdown were reversible within 168 h after siRNA injection, corresponding to the restoration of caveolin-1 expression. Thus our results demonstrate the essential requirement of caveolin-1 in mediating the formation of caveolae in endothelial cells in vivo and in negatively regulating IEJ permeability.
小窝蛋白-1是小窝的主要整合膜蛋白,参与调节小窝的结构完整性、囊泡运输和信号转导。尽管在小窝蛋白-1基因敲除小鼠中已开始探索小窝蛋白-1的功能,但这些结果因未知的代偿机制以及肺动脉高压、心肌病和肺纤维化的发展而受到混淆。为了研究小窝蛋白-1在调节肺血管通透性中的作用,在本研究中我们使用小干扰RNA(siRNA)在体内敲低小鼠肺内皮细胞中小窝蛋白-1的表达。与野生型小鼠相比,静脉注射包裹在脂质体中的针对小窝蛋白-1 mRNA的siRNA在注射后96小时内选择性地将小窝蛋白-1的表达降低了约90%。我们观察到肺血管内皮中小窝伴随消失,内皮间连接(IEJ)扩张,并且通过IEJ肺血管对白蛋白的通透性增加。小窝蛋白-1表达降低还导致血浆一氧化氮浓度升高。一氧化氮合酶抑制剂L-NAME部分阻断了血管白蛋白通透性的增加。小窝蛋白-1敲低的这些形态学和功能效应在siRNA注射后168小时内是可逆的,这与小窝蛋白-1表达的恢复相对应。因此,我们的结果证明了小窝蛋白-1在体内介导内皮细胞中小窝形成以及负向调节IEJ通透性方面的基本需求。